Article

Aspartame: Blinded Study Demonstrates Safety. Again.

Researchers investigating symptoms in people with self-reported aspartame sensitivity could find no substantive psychological or metabolic response to aspartame.

The artificial sweetener aspartame has elicited intense controversy and negative patient anecdotes since its approval in the 1980s. Cancer, blindness, and seizures, oh my! Frightfully misleading websites scare consumers about a litany of symptoms, many of which appear to be psychogenic. Many people believe that aspartame is a dangerous substance, and a subset of those people believe its use is part of a conspiracy to harm individuals and protect the huge industry that uses this sweetener. In Europe, in response to consumer apprehension, the European Food Safety Authority (EFSA) conducted a literature review of aspartame and created a database of the most commonly reported symptoms. However, few studies have studied aspartame’s systemic effects.

The March issue of PLOS ONE contains an article investigating self-reported aspartame sensitivity. The authors conducted a double-blind, randomized, cross-over study with 96 age- and gender-matched active and control arms. Forty-eight participants reported sensitivity to aspartame, and 48 reported no sensitivity. The researchers challenged participants with cereal bars containing 100 mg aspartame (equivalent to the amount consumed in a can of diet soda and less than the Acceptable Daily Intake maximum (ADI) recommended by FDA of 40 mg/kg body weight/day). Patients with food allergies or who had taken any medications in the 3 months prior to the study’s start date were excluded.

Aspartame-sensitive individuals were more likely to report symptoms after consuming aspartame or placebo (a cereal bar that looked and tasted like the aspartame-containing bar). Both aspartame and the control affected GLP-1, GIP, tyrosine, and phenylalanine levels equally. The results of in-depth psychological tests, biochemistry, and metabolic testing showed no substantive psychological or metabolic response to aspartame.

This study is another in a long series of studies indicating aspartame is a safe non-nutritive sweetener. Providers can confidently tell patients that aspartame lacks any acute harmful effects. FDA officials report that aspartame has been thoroughly tested and studied and is safe. Reassurance from a trusted source, such as endocrinologists, is key comfort for patients experiencing aspartame-induced anxiety.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
© 2025 MJH Life Sciences

All rights reserved.